<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) August 25, 2000
--------------------------------
CYGNUS, INC.
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 0-18962 94-2978092
--------------------------------------------------------------------------------
(State or other jurisdiction (Commission File (IRS Employer
of incorporation) Number) Identification No.)
400 PENOBSCOT DRIVE, REDWOOD CITY, CALIFORNIA 94063-4719
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (650) 369-4300
-----------------------------
NOT APPLICABLE
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS.
On October 16, 2000, we issued a press release, the text of
which is attached hereto as Exhibit 99.1, discussing international events
relating to our GlucoWatch-Registered Trademark- biographer.
On August 25, 2000, we signed a Warehouse Distribution Contract
with Livingston Healthcare Services Inc., a copy of which is attached hereto
as Exhibit 10.209, to provide outsource logistics services in the United
States for our GlucoWatch-Registered Trademark- system. The agreement covers
receiving, storage, customer service, technical support and shipment.
However, we are still solely responsible for the procurement, marketing and
sales of the GlucoWatch system. The term of the agreement is for five years,
but we may terminate the agreement before then with an early-termination
payment.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
EXHIBIT NUMBER
10.209 Warehouse Distribution Contract between Cygnus, Inc.
and Livingston Healthcare Services Inc., dated
August 25, 2000 referred to in Item 5 above.
(Certain information has been omitted from the
Agreement and filed separately with the Securities
and Exchange Commission pursuant to a request by us
for confidential treatment pursuant to Rule 24b.2.
The omitted confidential information has been
identified by the following statement "Confidential
Treatment Requested").
99.1 Press Release by Cygnus, Inc. dated October 16, 2000
referred to in Item 5 above.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CYGNUS, INC.
Date: October 16, 2000 By: /S/ BARBARA G. MCCLUNG
-----------------------------------
Barbara G. McClung
Senior Vice President
and General Counsel
